Approval · Notice of Compliance 38430 · 2026
JASCAYD: Notice of Compliance 38430
Issued October 8, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38430
- Date
- October 8, 2026
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
Medicinal ingredients
- NERANDOMILAST 9 MG per TAB
- NERANDOMILAST 18 MG per TAB